Slide 1

Global Aortic Aneurysm Market: Trends and Opportunities (2014-2019)

View Report Details

Scope of the ReportThe report titled Global Aortic Aneurysm Market: Trends and Opportunities (2014-2019) provides an in-depth analysis of global aortic aneurysm repair market with major focus on more prevalent endovascular abdominal aortic aneurysm repair. The report also provides detailed analysis of aortic aneurysm market in major regions like the US, Europe and Asia-Pacific. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2014-19). Further, key players of the industry such as Endologix, Medtronic, Gore Medical products and Cook Medical are also profiled in the report. Segment CoverageEndovascular Abdominal Aortic Aneurysm Repair (EVAR) Thoracic Endovascular Aortic Aneurysm (TEVAR)Geographical CoverageThe USEuropean Union

View Report DetailsAsia PacificCompany CoverageEndologix, Inc.Medtronic Inc.Cook MedicalGore Medical Products3Executive Summary

Aortic aneurysm is a general term used for enlargement for aorta which can lead to serious complications as it weakens the walls of the aorta. An aneurysm can develop anywhere along aorta but it mostly occurs in the section running through abdomen (abdominal aneurysms) and chest (thoracic aneurysms). Traditionally, open surgical repair of aneurysm was the only viable treatment option. In due course of time, more advanced minimally invasive Endovascular aneurysm repair(orendovascular aortic repair) (EVAR) or thoracic EVAR (TEVAR) has evolved. Endovascular aneurysm repair(orendovascular aortic repair) (EVAR) or Endovascular stent grafting is a type of endovascular surgeryused to treatpathologyof theaorta, most commonly anabdominal aortic aneurysm(AAA) or thoracic aortic aneurysm, the procedure thenspecifically termed TEVAR(thoracic endovascular aortic/aneurysm repair). Cases of aortic aneurysm have been growing at a rapid pace globally, majority being cases of abdominal aortic aneurysms. Some of the factors driving growth of the treatment market such as EVAR and TEVAR are rising geriatric population, increasing healthcare expenditure and shift from traditional to Minimally Invasive Surgeries (MIS). However, factors such as risk of complications associated with the treatment, legal and regulatory risk and global economic instability are posing challenge to industrys growth. Major trends prevailing in the industry are mergers and acquisitions, next-generation EVAR devices and dominance of infrarenal disease cases.Global Aortic Aneurysm Market : Overview

An aortic aneurysm is an abnormal bulge in the wall of the aorta, the body's largest artery (the blood vessel that carries oxygen-rich blood). Although an aneurysm can develop anywhere along aorta, it mostly occurs in the section running through abdomen (abdominal aneurysms).

Global Aortic Aneurysm Market Size, 2007-13 (US$ Billions)Market size of global aortic aneurysm market by value is expected to reach to US$ billion in the year 2019, from US$ billion in 2013 by growing at a CAGR of%. Growth in the market is due to .Global Aortic Aneurysm Market Size Forecasted, 2014E-19E (US$ Billions)

Global EVAR & TEVAR Market: Overview

Endovascular aneurysm repair(orendovascular aortic repair) (EVAR) or Endovascular stent grafting is a type of endovascular surgeryused to treatpathologyof theaorta, most commonly anabdominal aortic aneurysm(AAA) or thoracic aortic aneurysm, the procedure then specifically termed TEVAR(thoracic endovascular aortic/aneurysm repair).Global EVAR Market Size, 2008-13 (US$ Billions)Market size of global EVAR market by value is expected to reach to US$ billion in the year 2019, from US$ million in 2013 by growing at a CAGR of%. Growth in the market is due to .Global TEVAR Market Size, 2007-13 (US$ Millions)

Global Aortic Aneurysm Market Trends

Mergers & Acquisitions . .. .. .Next-Generation EVAR Devices .. .. Dominance of Infrarenal Disease .. .. 1. Executive Summary2. Aortic Aneurysm2.1 Overview2.2 Aortic Aneurysms: Types2.2.1 Thoracic Aortic Aneurysm2.2.2 Abdominal Aortic Aneurysm2.3 Global Aortic Aneurysm Repair Market Analysis2.3.1 Global Aortic Aneurysm Repair Market Sizing (Actual & Forecasted)2.3.2 Global Aortic Aneurysm Repair Market Share by Category (Actual & Forecasted)2.4 Aortic Aneurysm: Treatment2.4.1 Limitations of Treatment Options3.Endovascular & Thoracic Aortic Aneurysm Repair Market3.1 Overview3.1.1 Benefits and Risks3.2 Endovascular Stent Grafting Procedure3.3 EVAR Devices4.Global Aortic Aneurysm Market Analysis4.1 Global Abdominal Endovascular Aortic Repair (EVAR) Market Sizing (Actual & Forecasted)

4.2 Global Thoracic Endovascular Aortic Aneurysm (TEVAR) Market Size (Actual & Forecasted)4.3 Global Abdominal EVAR Market Share4.3.1 By Competitors4.3.2 By Geography4.3.3 By Neck Length5. Global Aortic Aneurysm Market: Country Analysis5.1 The US EVAR Market5.1.1 The US EVAR Market Size by Volume5.1.2 The US EVAR Market Size by Value (Actual & Forecasted)5.1.3 The US TEVAR Market Size by Value (Actual & Forecasted)5.1.4 Market Share by Competitors5.1.5 Market Share by AAA Procedures5.2 European Union EVAR Market5.3 Asia-Pacific EVAR MarketGlobal Aortic Aneurysm Market Growth Drivers & Challenges6.1 Growth Drivers6.1.1 Ageing Population6.1.2 Rising Healthcare Expenditure

Table of Contents

Table of Contents6.1.3 Shift from Traditional to Minimally Invasive Surgeries (MIS)6.2 Challenges6.2.1 Risk of Associated Complications6.2.2 Legal and Regulatory Risk6.2.3 Worldwide Economic Instability7.Global Aortic Aneurysm Market Trends7.1 Mergers & Acquisitions7.2 Next-Generation EVAR Devices7.3 Dominance of Infrarenal Disease8.Competitive Landscape9. Company Profiles9.1 Medtronic Inc.9.1.1 Business Overview9.1.2 Financial Overview9.1.3 Business Strategies9.2 Endologix, Inc.9.2.1 Business Overview9.2.2 Financial Overview9.2.3 Business Strategies9.3 Cook Medical (Cook Group Incorporated)9.3.1 Business Overview9.4 Gore Medical Products (W.L. Gore & Associates)9.4.1 Business Overview

9List of ChartsFigure 1: Anatomy of Human Aorta in Abdominal and Thoracic Aortic AneurysmFigure 2: Thoracic Aortic Aneurysm (TAA)Figure 3: Abdominal Aortic Aneurysm (AAA)Figure 4: Global Aortic Aneurysm Repair Market Size by Value, 2007-13 (US$ Billions)Figure 5: Global Aortic Aneurysm Repair Market Size by Value Forecasted, 2014E-19E (US$ Billions)Figure 6: Global Aortic Aneurysm Repair Market Share by Category (2014E)Figure 7: Global Aortic Aneurysm Repair Market Share by Category Forecasted (2019E)Figure 8: Abdominal & Thoracic Aortic AneurysmTable 1: Advantages and Disadvantages of AAA EVARFigure 9: Endovascular Stent Grafting ProcedureTable 2: FDA-approved EVAR Devices (August 2013)Figure 10: Global Abdominal Endovascular Aortic Repair (EVAR) Market Size by Value, 2007-13 (US$ Billions)Figure 11: Global Endovascular Abdominal Aortic Aneurysm Repair (EVAR) Market Size by Value Forecasted, 2014E-19E (US$ Millions)Figure 12: Global Thoracic Endovascular Aortic Aneurysm (TEVAR) Market Size, 2007-13 (US$ Millions)Figure 13: Global Thoracic Endovascular Aortic Aneurysm (TEVAR) Market Size Forecast, 2014E-19E (US$ Millions)Figure 14: Global Abdominal Aortic Aneurysm (AAA) Repair Market Share by Competitors (2013)Figure 15: Global Abdominal Aortic Aneurysm (AAA) Repair Market Share by Competitors Forecasted (2017E)Figure 16: Global EVAR Market Share by Geography (2013E)Figure 17: Global EVAR Market Penetration by Neck Length (2014E)Figure 18: The US Endovascular Abdominal Aortic Aneurysm (EVAR) Market Size by Volume & EVAR Penetration, 2007-12 (Units)10Figure 19: The US Endovascular Abdominal Aortic Aneurysm (EVAR) Market Size by Value, 2007-13E (US$ Millions)Figure 20: The US Endovascular Abdominal Aortic Aneurysm (EVAR) Market Size by Value Forecasted, 2014E-19E (US$ Billions)Figure 21: The US Thoracic Endovascular Aortic Aneurysm (TEVAR) Market Size by Value, 2007-13E (US$ Millions)Figure 22: The US Thoracic Endovascular Aortic Aneurysm (TEVAR) Market Size by Value Forecasted, 2014E-19E (US$ Millions)Figure 23: The US AAA Market Share by Competitors (2013)Figure 24: The US AAA Market Share by Competitors Forecasted (2017E)Figure 25: AAA Procedures in the US (2012)Figure 26: European Union EVAR Market Size, 2013-19E (US$ Millions)Figure 27: Asia Pacific TEVAR Market Size by Volume in Leading Nations, 2012 (Units)Figure 28: Global Aging Population, 2005-13E (Millions)Figure 29: Global Healthcare Expenditure, 2007-17E (US$ Trillions)Table 3: Complications of Endovascular Repair of Abdominal and Thoracic Aortic AneurysmTable 4: Mergers & Acquisitions of Aortic Endograft CompaniesFigure 30: Global EVAR Market Penetration by Neck Length (2014E)Figure 31: Global EVAR Current Revenues and Market Opportunity by Neck Length, 2014E (US$ Millions)Figure 32: EVAR Limb Intervention Rate Comparison by CompetitorsTable 4: EVAR Devices by Leading Market PlayersTable 5: Endologix New Products Pipeline, 2013-17EFigure 33: Medtronic Inc. Revenue by Business Segment (FY13)Figure 34: Medtronic Inc. Endovascular Business Segment Revenue, FY11-FY13 (US$ Millions)Figure 35: Endologix, Inc. Revenue, FY11-FY13 (US$ Millions)11Daedal ResearchDaedal Research is a research and consulting firm specialized in providing research reports and customized business research and analysis. The research firm offers a blend of the best strategic consulting and market research solutions, which promise data rich, cost effective, and highly insightful analysis to help its clients with perfect answers to their important business queries.For more details please contact Mr. Rajeev Kumar:

Tel: +91-120-4553017(9.30 am - 6.30 pm) ISTMobile: +91-8743975789(24 X7)Enquiries: info@daedal-research.comTitle: Global Aortic Aneurysm Market: Trends & Opportunities (2014-19)Published: June 2014Pages: 70Price: US$ 800 (Single-User License) : US$ 1600 (Corporate License)

For placing an order of the Report, please press the following link:http://www.daedal-research.com/global-aortic-aneurysm-market-trends-and-opportunities-2014-2019 Chart1

Sheet1Global EVAR Market by Geography2013EUnited States54%Europe28%Asia-Pacific10%Latin America5%Others3% AAA Procedures in the US2012EVAR75%Open25%Global AAA Market Breakdown by Category2013EVAR1200TEVAR450FEVAR601480Global EVAR/TEVAR MarketUS$ Bn20070.9820081.1220091.2620101.4320111.6120121.7520131.86US$ Bn2014E1.965.38922155692015E2.106.81818181822016E2.215.31914893622017E2.325.05050505052018E2.412019E2.50Global AAA MarketUS$ Mn20078261.8520089382.1200910162.275201011612.6201112952.9201214173.175201315073.375US$ Bn2014E1.563.53.47682119212015E1.653.75.71428571432016E1.723.854.05405405412017E1.7943.89610389612018E1.853,105,000.002019E1.92

Global TAA MarketUS$ Mn20071560.3520081790.420092460.5520102680.620113130.720123350.7520133570.8US$ Bn2014E4020.940815.04218795462015E446111.11111111112016E4911.1102017E5361.29.09090909092018E5572019E579Global AAA Makrte by Pahtology Type2013Abdominal Aortic Aneurysm (AAA)1507Thoracic Aortic Aneurysm (TAA)3572019EAbdominal Aortic Aneurysm (AAA)1920Thoracic Aortic Aneurysm (TAA)579Global AAA Market Share2013Medtronic40.6%Cook30.0%Gore14.8%Endologix3.7%Trivascular1.1%Lombard0.8%Others9.1%2017EMedtronic36.9%Cook27.3%Gore13.7%Endologix8.0%Trivascular2.9%Lombard1.9%J&J1.7%Others7.8%EVAR Limb Intervention Rate Comapirson by Competotors2014EMDT Endurant3.9%MDT Talent3.3%Cook Zenith2.8%Gore Excluder1.7%ELGX Powelink1.2%

Sheet2Global healthcare expenditureUS$ Trillion20075.5620086.0620095.8420106.2020116.4820126.782013E7.102014E7.432015E7.782016E8.182017E8.60

CompaniesMedtronic revenue by business group2013Spine19%Neuromodualstion11%Diabetes9%Surgical Technologies9%Endovascular5%Structural Heart7%Coronary11%Cardiac Rhythm Disease Management30%101%Medtronic revenue endovascular segemntUS$ MnFY11666FY12783FY138670.107279693525.2832.750.2954905063Endologix Revenue US$ MillionsFY1183.42FY12105.95FY13132.260.2483246815

Chart9

Sheet1Global EVAR Market by Geography2013EUnited States54%Europe28%Asia-Pacific10%Latin America5%Others3% AAA Procedures in the US2012EVAR75%Open25%Global AAA Market Breakdown by Category2013EVAR1200TEVAR450FEVAR60Global EVAR/TEVAR MarketUS$ Bn20070.9820081.1220091.2620101.4320111.6120121.7520131.86US$ Bn2014E1.965.38922155692015E2.106.81818181822016E2.215.31914893622017E2.325.05050505052018E2.412019E2.50Global AAA MarketUS$ Mn20078261.8520089382.1200910162.275201011612.6201112952.9201214173.175201315073.375US$ Bn2014E1.563.53.47682119212015E1.653.75.71428571432016E1.723.854.05405405412017E1.7943.89610389612018E1.852019E1.92

Global TAA MarketUS$ Mn20071560.3520081790.420092460.5520102680.620113130.720123350.7520133570.8US$ Bn2014E4020.940815.04218795462015E446111.11111111112016E4911.1102017E5361.29.09090909092018E5572019E579

Sheet2

CompaniesEndlogix

Chart1

Sheet1Global EVAR Market by Geography2013EUnited States54%Europe28%Asia-Pacific10%Latin America5%Others3% AAA Procedures in the US2012EVAR75%Open25%Global AAA Market Breakdown by Category2013EVAR1200TEVAR450FEVAR601480Global EVAR/TEVAR MarketUS$ Bn20070.1620080.1820090.2520100.2720110.3120120.3420130.360.0666511767US$ Bn2014E1.96447.68943519532015E2.106.81818181822016E2.215.31914893622017E2.325.05050505052018E2.412019E2.50Global AAA MarketUS$ Mn20070.831.8520080.942.120091.022.27520101.162.620111.292.920121.423.17520131.513.375US$ Bn2014E1.563.53.47682119212015E1.653.75.71428571432016E1.723.854.05405405412017E1.7943.89610389612018E1.853,105,000.002019E1.922.50

Global TAA MarketUS$ Mn20071560.3520081790.420092460.5520102680.620113130.720123350.7520133570.8US$ Bn2014E4020.940815.04218795462015E446111.11111111112016E4911.1102017E5361.29.09090909092018E5572019E579Global AAA Makrte by Pahtology Type2013Abdominal Aortic Aneurysm (AAA)1507Thoracic Aortic Aneurysm (TAA)3572019EAbdominal Aortic Aneurysm (AAA)1920Thoracic Aortic Aneurysm (TAA)579Global AAA Market Share2013Medtronic40.6%Cook30.0%Gore14.8%Endologix3.7%Trivascular1.1%Lombard0.8%Others9.1%2017EMedtronic36.9%Cook27.3%Gore13.7%Endologix8.0%Trivascular2.9%Lombard1.9%J&J1.7%Others7.8%EVAR Limb Intervention Rate Comapirson by Competotors2014EMDT Endurant3.9%MDT Talent3.3%Cook Zenith2.8%Gore Excluder1.7%ELGX Powelink1.2%

Sheet2Global healthcare expenditureUS$ Trillion20075.5620086.0620095.8420106.2020116.4820126.782013E7.102014E7.432015E7.782016E8.182017E8.60

CompaniesMedtronic revenue by business group2013Spine19%Neuromodualstion11%Diabetes9%Surgical Technologies9%Endovascular5%Structural Heart7%Coronary11%Cardiac Rhythm Disease Management30%101%Medtronic revenue endovascular segemntUS$ MnFY11666FY12783FY138670.107279693525.2832.750.2954905063Endologix Revenue US$ MillionsFY1183.42FY12105.95FY13132.260.2483246815

Chart7

Sheet1Global EVAR Market by Geography2013EUnited States54%Europe28%Asia-Pacific10%Latin America5%Others3% AAA Procedures in the US2012EVAR75%Open25%Global AAA Market Breakdown by Category2013EVAR1200TEVAR450FEVAR60Global EVAR/TEVAR MarketUS$ Bn20070.9820081.1220091.2620101.4320111.6120121.7520131.86US$ Bn2014E1.965.38922155692015E2.106.81818181822016E2.7731.95744680852017E2.32-16.15607868432018E2.382019E2.43Global AAA MarketUS$ Mn20078261.8520089382.1200910162.275201011612.6201112952.9201214173.175201315073.375US$ Bn2014E1.563.53.47682119212015E1.653.75.71428571432016E1.723.854.05405405412017E1.7943.89610389612018E1.852019E1.92

Global TAA MarketUS$ Mn20071560.3520081790.420092460.5520102680.620113130.720123350.7520133570.8US$ Bn2014E0.400.9-59.0849578122015E0.45111.11111111112016E1.051.1135.22017E0.541.2-48.97959183672018E0.562019E0.58

Sheet2

CompaniesEndlogix